Trimetazidine – Cardiology MCQ
Trimetazidine is an antianginal agent which acts by inhibition of:
A. Beta oxidation of fatty acids
B. Anaerobic metabolism of glucose
C. Calcium channels
D. Beta adrenergic receptors
Please check the YouTube video above for discussion
Related Posts
-
Marker of successful ablation of AVNRT – Cardiology MCQ
No Comments | Jan 23, 2011
-
Recurrence of venous thromboembolism – Cardiology MCQ
No Comments | May 12, 2015
-
Nocturnal hypertension – Cardiology MCQ
No Comments | Oct 27, 2013
-
Endothelium derived vasodilator – Cardiology MCQ – Answer
No Comments | Dec 26, 2018
About The Author
Johnson Francis
Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal